YILI(SH:600887) 新消费智库·2025-10-19 13:03New Product Launches - "Moli Milk White" has launched a seasonal limited edition of taro-flavored products, including Taro Cream Cheese Milk and Taro Cheese Milk, featuring a multi-layered flavor profile [5][6] - Sanyuan Foods has introduced a new lactic acid bacteria drink called "BUFFAMIN," which is sugar-free, calorie-free, and fat-free, priced at 54.2 yuan for a pack of four 340ml bottles [6][9] - Labubu has collaborated with Topps to release a limited edition of collectible cards, including signed cards and special edition cards, set to launch on October 20 [6][7] - Baby World and Ai Ying Shi have jointly launched a zero complementary food series, covering essential categories like fruit puree and rice cereal [6][9] - Qing Shang has introduced a new product, "Qing Shang Red Ginseng Energy Drink with Pomegranate Flavor," which contains collagen peptides and is priced at 25.9 yuan for a pack of five 60ml bottles [6][9] - Heytea has partnered with celebrity chef Ran Shao to launch a new Mojito-inspired drink, combining fresh mint and lime flavors [6][9] - Card Game Company has launched the first officially licensed NBA player cards in China, in collaboration with Fanatics Collectibles [10] - Suntory has released a new "Craft Boss Sweet Peach Tea Latte," priced at approximately 9.7 yuan per bottle [10][11] Industry Events - Yili has announced a new cheese product and appointed Yi Li Jing as the brand ambassador, launching a new cheese spread available in original, mustard, and tomato flavors [12] - New Tianli Technology has successfully passed the IPO review for the Beijing Stock Exchange, with clients including major food enterprises [12] - Luckin Coffee has collaborated with the game "Honor of Kings" to launch a new drink featuring real sour fruit juice [14] - Mengniu has established a new company in Lanzhou, focusing on internet live streaming technology services and food sales [27] Investment and Financing Trends - Zao Wu Shi has completed a Pre-A round financing of several million yuan, led by Qiming Venture Partners, to enhance core technology and expand market channels [19] - Pianzaihuang has committed 2 billion yuan to participate in a 10 billion yuan medical fund, with a 20% stake [21] - Oura has raised 900 million USD, achieving a valuation of approximately 11 billion USD [22] - Anten Biotech has completed an angel round financing, with funds directed towards product development and research [28]